Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Anticoagulants - adverse effects"'
Publikováno v:
Acta Médica Portuguesa, Vol 37, Iss 4 (2024)
N/a.
Externí odkaz:
https://doaj.org/article/6e9bde8a92b4452082b8ba88caa29295
Publikováno v:
Acta Médica Portuguesa, Vol 36, Iss 3, Pp 206-209 (2022)
Wunderlich syndrome is a rare and possibly life-threatening haemorrhagic syndrome presenting as spontaneous nontraumatic renal rupture with subcapsular and perinephric haemorrhage. Apixaban, a direct oral anticoagulant recommended in patients with at
Externí odkaz:
https://doaj.org/article/ea262a46b43546c4bb83403d6efbcaa2
Autor:
Ana Almeida Pereira, Mariana Martins, Vítor Brás Silva, Marta Amaral Silva, Ana Catarina Miguéns
Publikováno v:
Acta Médica Portuguesa, Vol 36, Iss 3, Pp 218-219 (2023)
N/a.
Externí odkaz:
https://doaj.org/article/82abfa1f5a0c4d89bba502ddbee6bee7
Autor:
Márcio Augusto Silva, Guilherme Muller de Campos Futuro, Erick Sessa Merçon, Deborah Vasconcelos, Rovana Silva Agrizzi, Jorge Elias Neto, Ricardo Kuniyoshi
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 114, Iss 3, Pp 435-442 (2020)
Abstract Background: Atrial fibrillation (AF) ablation under uninterrupted warfarin use is safe and recommended by experts. However, there is some controversy regarding direct-acting oral anticoagulants for the same purpose. Objective: To evaluate th
Externí odkaz:
https://doaj.org/article/744a1f242c6d4e37a75be5ceabe6a144
Autor:
Pedro Gabriel Melo de Barros e Silva, Henry Sznejder, Rafael Vasconcellos, Georgette M. Charles, Hugo Tannus F. Mendonca-Filho, Jack Mardekian, Rodrigo Nascimento, Stephen Dukacz, Manuela Di Fusco
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 114, Iss 3, Pp 457-466 (2020)
Abstract Background: The safety and effectiveness of warfarin depend on anticoagulation control quality. Observational studies associate poor control with increased morbidity, mortality and healthcare costs. Objectives: To develop a profile of non-va
Externí odkaz:
https://doaj.org/article/42498726664d47f9a27f2a9070c1fc9e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kwok, Chun Shing, Bennett, Sadie, Borovac, Josip A., Will, Maximilliam, Schwarz, Konstantin, Lip, Gregory Y H
Publikováno v:
Kwok, C S, Bennett, S, Borovac, J A, Will, M, Schwarz, K & Lip, G Y H 2023, ' An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution : a systematic review, pooled analysis and meta-analysis ', Coronary Artery Disease, vol. 34, no. 4, pp. 260-273 . https://doi.org/10.1097/MCA.0000000000001230
Left ventricular thrombus (LVT) is a recognized complication of acute myocardial infarction which is associated with stroke. There has yet to be a published systematic review that focuses on outcomes for patients with LVT. We conducted a systematic r
Publikováno v:
Elsheikh, S, Tidbury, N & Lip, G Y H 2023, ' A review of emerging factor XI inhibitors ', Expert Opinion on Emerging Drugs, vol. 28, no. 1, pp. 43-53 . https://doi.org/10.1080/14728214.2023.2192923
Introduction: Whilst the introduction of direct oral anticoagulants (DOACs) has improved the prevention of thromboembolic events, there is still a need for safer anticoagulants. This is particularly so, for specific populations of patients, such as t
Autor:
Nicklas Vinter, Olli Halminen, Mika Lehto, K. E. Juhani Airaksinen, Tomas Andersson, Per Wändell, Martin Holzmann, Ole‐Christian Rutherford, Sigrun Halvorsen, Pia Cordsen, Lars Frost, Søren Paaske Johnsen
Publikováno v:
Vinter, N, Halminen, O, Lehto, M, Airaksinen, K E J, Andersson, T, Wändell, P, Holzmann, M, Rutherford, O-C, Halvorsen, S, Cordsen, P, Frost, L & Johnsen, S P 2023, ' Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway, and Finland ', Basic & Clinical Pharmacology & Toxicology, vol. 133, no. 2, pp. 168-178 . https://doi.org/10.1111/bcpt.13902
Vinter, N, Halminen, O, Lehto, M, Airaksinen, K E J, Andersson, T, Wändell, P, Holzmann, M, Rutherford, O-C, Halvorsen, S, Cordsen, P, Frost, L & Johnsen, S P 2023, ' Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway, and Finland ', Basic & Clinical Pharmacology & Toxicology . https://doi.org/10.1111/bcpt.13902
Vinter, N, Halminen, O, Lehto, M, Airaksinen, K E J, Andersson, T, Wändell, P, Holzmann, M, Rutherford, O-C, Halvorsen, S, Cordsen, P, Frost, L & Johnsen, S P 2023, ' Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway, and Finland ', Basic & Clinical Pharmacology & Toxicology . https://doi.org/10.1111/bcpt.13902
AimTo examine inter-national and regional variations in persistence of oral anticoagulation (OAC) therapy and incidence of clinical outcomes and mortality, among patients with incident atrial fibrillation (AF) in the Nordic countries.MethodsWe conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621048389af5f35b1d890066296c07f8
https://pure.au.dk/portal/da/publications/geographical-variation-in-persistence-to-oral-anticoagulation-therapy-and-clinical-outcomes-among-patients-with-atrial-fibrillation-initiating-therapy-in-denmark-sweden-norway-and-finland(f55eac3a-8901-49b7-8901-c4733d7f51ba).html
https://pure.au.dk/portal/da/publications/geographical-variation-in-persistence-to-oral-anticoagulation-therapy-and-clinical-outcomes-among-patients-with-atrial-fibrillation-initiating-therapy-in-denmark-sweden-norway-and-finland(f55eac3a-8901-49b7-8901-c4733d7f51ba).html
Autor:
Ntaios, George, Sagris, Dimitrios, Buckley, Benjamin J. R., Harrison, Stephanie L., Abdul-Rahim, Azmil, Austin, Philip, Lip, Gregory Y. H.
Publikováno v:
Ntaios, G, Sagris, D, Buckley, B J R, Harrison, S L, Abdul-Rahim, A, Austin, P & Lip, G Y H 2023, ' Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation ', Europace, vol. 25, no. 6, euad143 . https://doi.org/10.1093/europace/euad143
AimsThere is conflicting evidence on whether the type of atrial fibrillation (AF) is associated with risk of cardiovascular events, including acute myocardial infarction (MI) and ischemic stroke. The aim of the present study was to investigate whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1266::fdf472cae7f6eee58648704b2129cf8a
https://vbn.aau.dk/ws/files/535566318/Ntaios_et_al._2023_._Risk_of_myocardial_infarction_and_ischemic_stroke_in_individuals_with_first_diagnosed_paroxysmal_vs._non_paroxysmal_atrial_fibrillation_under_anticoagulation.pdf
https://vbn.aau.dk/ws/files/535566318/Ntaios_et_al._2023_._Risk_of_myocardial_infarction_and_ischemic_stroke_in_individuals_with_first_diagnosed_paroxysmal_vs._non_paroxysmal_atrial_fibrillation_under_anticoagulation.pdf